Consequently, our discovery of Sema3C as a novel biomarker highlights its key role in mediating bidirectional communication between CSCs and the tumor stroma, driving a vicious cycle that accelerates HCC progression (Fig. 8i). Here, SEMA3C is linked to neoplasm.